Kangabio AUSTRALIA LTD PTY
Kangabio AUSTRALIA LTD PTY
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of Single-Agent KGX105 in Patients With Advanced or Metastatic Solid Tumors | Advanced or Metastatic Solid Tumors | Not yet recruiting | Phase 1 | 2026-07-21 | NCT07702955 | |
| This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors. | Advanced or Metastatic Solid Tumors | Active, not recruiting | Phase 1 | 2026-04-29 | NCT06074497 | |
| A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients | Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-04-24 | NCT07260305 |